SCHEMBL20989488

SCHEMBL20989488

Cc1cnc(C(C)I)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL765512 0.81
SCHEMBL12179253 0.77
SCHEMBL4485938 0.77
SCHEMBL19286511 0.77
SCHEMBL18066903 0.77 NOS1 (0.43)
SCHEMBL24963250 0.77
SCHEMBL20363468 0.76 CDK2 (0.41)
Hydrochloric Acid SCHEMBL6232536 0.76 NOS1 (0.46)
Hydrochloric Acid SCHEMBL11901378 0.76 NOS1 (0.46)
Hydrochloric Acid SCHEMBL1803155 0.76 NOS1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640510-B2 Metabotrophic glutamate receptor 5 modulators and methods use thereof SUNOVION PHARMACEUTICALS INC. (US) 2020-05-05 US disclosed
US-20190135815-A1 METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS USE THEREOF SUNOVION PHARMACEUTICALS INC (US) 2019-05-09 US disclosed